Research Article
The futility of current approaches to chondroprotection
David T. Felson,
Young-Jo Kim,
Corresponding Author
David T. Felson
Boston University School of Medicine, and Children's Hospital–Boston, Harvard Medical School, Boston, Massachusetts
A203, 80 East Concord Street, Boston University School of Medicine, Boston, MA 02118Search for more papers by this authorYoung-Jo Kim
Boston University School of Medicine, and Children's Hospital–Boston, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorDavid T. Felson,
Young-Jo Kim,
Corresponding Author
David T. Felson
Boston University School of Medicine, and Children's Hospital–Boston, Harvard Medical School, Boston, Massachusetts
A203, 80 East Concord Street, Boston University School of Medicine, Boston, MA 02118Search for more papers by this authorYoung-Jo Kim
Boston University School of Medicine, and Children's Hospital–Boston, Harvard Medical School, Boston, Massachusetts
Search for more papers by this author
REFERENCES
- 1 Van Offel JF, Schuerwegh AJ, Bridts CH, Stevens WJ, De Clerck LS. Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis 2002; 61: 925–8.
- 2 Van Offel JF, Dombrecht EJ, Bridts CH, Schuerwegh AJ, Ebo DG, Stevens WJ, et al. Influence of bisphosphonates on the production of pro-inflammatory cytokines by activated human articular chondrocytes. Cytokine 2005; 31: 298–304.
- 3 Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial. Arthritis Res Ther 2005; 7: R625–33.
- 4 Bingham CO III, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006; 54: 3494–507.
- 5 Smith GN Jr, Brandt KD, Hasty KA. Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum 1996; 39: 235–44.
- 6 Schlopov BV, Smith GN Jr, Cole AA, Hasty KA. Differential patterns of response to doxycycline and transforming growth factor β1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Arthritis Rheum 1999; 42: 719–27.
- 7 Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 2005; 52: 2015–25.
- 8 Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002; 162: 2113–23.
- 9 Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357: 251–6.
- 10 Felson DT, Goggins J, Niu J, Zhang Y, Hunter DJ. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum 2004; 50: 3904–9.
- 11 Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003; 139: 330–6.
- 12 Bendele A, McComb J, Gould T, McAbee T, Sennello G, Chlipala E, et al. Animal models of arthritis: relevance to human disease. Toxicol Pathol 1999; 27: 134–42.
- 13 Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [review]. Arthritis Rheum 2001; 44: 1237–47.
- 14 Amin S, LaValley MP, Guermazi A, Grigoryan M, Hunter DJ, Clancy M, et al. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum 2005; 52: 3152–9.
- 15 Hunter DJ, Zhang YQ, Niu JB, Tu X, Amin S, Clancy M, et al. The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum 2006; 54: 795–801.
- 16 Eckstein F, Heudorfer L, Faber SC, Burgkart R, Englmeier KH, Reiser M. Long-term and resegmentation precision of quantitative cartilage MR imaging (qMRI). Osteoarthritis Cartilage 2002; 10: 922–8.
- 17 Burgkart R, Glaser C, Hyhlik-Durr A, Englmeier KH, Reiser M, Eckstein F. Magnetic resonance imaging–based assessment of cartilage loss in severe osteoarthritis: accuracy, precision, and diagnostic value. Arthritis Rheum 2001; 44: 2072–7.
- 18 Eckstein F, Glaser C. Measuring cartilage morphology with quantitative magnetic resonance imaging [review]. Semin Musculoskelet Radiol 2004; 8: 329–53.
- 19 Amin S, Niu JB, LaValley M, Guermazi A, Grigoryan M, Hunter DJ, et al. Cartilage loss of the knee on MRI is not related to progression of knee pain or disability [abstract]. Arthritis Rheum 2004; 50 Suppl 9: S141.
- 20 Torres L, Dunlop DD, Peterfy C, Guermazi A, Prasad P, Hayes KW, et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006; 14: 1033–40.
- 21 Roos EM, Dahlberg L. Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum 2005; 52: 3507–14.
- 22 Cunningham T, Jessel R, Zurakowski D, Millis MB, Kim YJ. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage to predict early failure of Bernese periacetabular osteotomy for hip dysplasia. J Bone Joint Surg Am 2006; 88: 1540–8.
- 23 Kim YJ, Jessel R, Cunningham T, Zurakowski D, Millis MB, Jaramillo D, et al. Response of articular cartilage to periacetabular osteotomy for hip dysplasia. Orthopaedic Research Society Meetings, Washington DC. 2005.
- 24 Cho YM, Youn BS, Chung SS, Kim KW, Lee HK, Yu KY, et al. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans [published erratum appears in Diabetologia 2004;47:1337–8]. Diabetologia 2004; 47: 559–65.
- 25 Kirkley A, Webster-Bogaert S, Litchfield R, Amendola A, MacDonald S, McCalden R, et al. The effect of bracing on varus gonarthrosis. J Bone Joint Surg Am 1999; 81: 539–48.
- 26 Pollo FE, Otis JC, Backus SI, Warren RF, Wickiewicz TL. Reduction of medial compartment loads with valgus bracing of the osteoarthritic knee. Am J Sports Med 2002; 30: 414–21.
- 27 Toda Y, Segal N. Usefulness of an insole with subtalar strapping for analgesia in patients with medial compartment osteoarthritis of the knee. Arthritis Rheum 2002; 47: 468–73.
- 28 Hinman RS, Crossley KM, McConnell J, Bennell KL. Efficacy of knee tape in the management of osteoarthritis of the knee: blinded randomised controlled trial. BMJ 2003; 327: 135.
- 29 Amin S, Luepongsak N, McGibbon CA, LaValley MP, Krebs DE, Felson DT. Knee adduction moment and development of chronic knee pain in elders. Arthritis Rheum 2004; 51: 371–6.
- 30 Hunter DJ, Zhang Y, Niu J, Goggins J, Amin S, LaValley MP, et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006; 54: 1529–35.
- 31 Hunter DJ, Zhang Y, Sokolove J, Nin J, Aliabadi P, Felson DT. Trapeziometacarpal subluxation predisposes to incident trapeziometacarpal osteoarthritis (OA): the Framingham Study. Osteoarthritis Cartilage 2005; 13: 953–7.
